elysium neurological services (badby) limited
elysium neurological services (badby) limited Company Information
Company Number
05558328
Next Accounts
13 days late
Shareholders
elysium neurological services limited
Group Structure
View All
Industry
Medical nursing home activities
Registered Address
2 imperial place, maxwell road, borehamwood, hertfordshire, WD6 1JN
Website
badbypark.co.ukelysium neurological services (badby) limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED at £17.6m based on a Turnover of £27.2m and 0.65x industry multiple (adjusted for size and gross margin).
elysium neurological services (badby) limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED at £0 based on an EBITDA of £-1.7m and a 4.63x industry multiple (adjusted for size and gross margin).
elysium neurological services (badby) limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED at £0 based on Net Assets of £-11m and 2.62x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elysium Neurological Services (badby) Limited Overview
Elysium Neurological Services (badby) Limited is a live company located in hertfordshire, WD6 1JN with a Companies House number of 05558328. It operates in the medical nursing home activities sector, SIC Code 86102. Founded in September 2005, it's largest shareholder is elysium neurological services limited with a 100% stake. Elysium Neurological Services (badby) Limited is a mature, large sized company, Pomanda has estimated its turnover at £27.2m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Elysium Neurological Services (badby) Limited Health Check
Pomanda's financial health check has awarded Elysium Neurological Services (Badby) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 5 areas for improvement. Company Health Check FAQs
6 Strong
0 Regular
5 Weak
Size
annual sales of £27.2m, make it larger than the average company (£4.3m)
£27.2m - Elysium Neurological Services (badby) Limited
£4.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 33%, show it is growing at a faster rate (5.6%)
33% - Elysium Neurological Services (badby) Limited
5.6% - Industry AVG
Production
with a gross margin of 14.5%, this company has a higher cost of product (37.1%)
14.5% - Elysium Neurological Services (badby) Limited
37.1% - Industry AVG
Profitability
an operating margin of -9.5% make it less profitable than the average company (10.4%)
-9.5% - Elysium Neurological Services (badby) Limited
10.4% - Industry AVG
Employees
with 397 employees, this is above the industry average (102)
397 - Elysium Neurological Services (badby) Limited
102 - Industry AVG
Pay Structure
on an average salary of £43k, the company has a higher pay structure (£28.4k)
£43k - Elysium Neurological Services (badby) Limited
£28.4k - Industry AVG
Efficiency
resulting in sales per employee of £68.6k, this is more efficient (£50.1k)
£68.6k - Elysium Neurological Services (badby) Limited
£50.1k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (23 days)
0 days - Elysium Neurological Services (badby) Limited
23 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Neurological Services (badby) Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (1 days)
0 days - Elysium Neurological Services (badby) Limited
1 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (27 weeks)
0 weeks - Elysium Neurological Services (badby) Limited
27 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 265.1%, this is a higher level of debt than the average (48.2%)
265.1% - Elysium Neurological Services (badby) Limited
48.2% - Industry AVG
ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED financials
Elysium Neurological Services (Badby) Limited's latest turnover from June 2023 is £27.2 million and the company has net assets of -£11 million. According to their latest financial statements, Elysium Neurological Services (Badby) Limited has 397 employees and maintains cash reserves of £4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 27,231,000 | 14,346,000 | 11,698,000 | 8,446,000 | 7,353,000 | 7,283,000 | 6,461,000 | 6,456,259 | 5,683,000 | 4,837,000 | 4,414,000 | 3,329,000 | 1,583,779 | |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | 23,279,000 | 12,016,000 | 10,387,000 | 7,120,000 | 6,648,000 | 6,160,000 | 3,850,000 | 3,735,110 | 2,749,000 | 2,541,000 | 2,494,000 | 2,435,000 | 1,649,629 | |
| Gross Profit | 3,952,000 | 2,330,000 | 1,311,000 | 1,326,000 | 705,000 | 1,123,000 | 2,611,000 | 2,721,149 | 2,934,000 | 2,296,000 | 1,920,000 | 894,000 | -65,850 | |
| Admin Expenses | 6,533,000 | 3,396,000 | 2,962,000 | 2,936,000 | 2,847,000 | 2,957,000 | 2,572,000 | 2,221,135 | 2,056,000 | 1,910,000 | 1,563,000 | 1,008,000 | 1,127,570 | |
| Operating Profit | -2,581,000 | -1,066,000 | -1,651,000 | -1,610,000 | -2,142,000 | -1,834,000 | 39,000 | 500,014 | 878,000 | 386,000 | 357,000 | -114,000 | -1,193,420 | |
| Interest Payable | 1,000 | 1,000 | 1,000 | 289,000 | 345,000 | 765,256 | ||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | -2,581,000 | -1,066,000 | -1,651,000 | -1,610,000 | -2,142,000 | -1,835,000 | 39,000 | 500,014 | 877,000 | 385,000 | 68,000 | -459,000 | -1,958,676 | |
| Tax | -38,000 | -36,000 | -11,000 | -14,000 | -8,000 | 53,000 | ||||||||
| Profit After Tax | -2,619,000 | -1,102,000 | -1,662,000 | -1,624,000 | -2,150,000 | -1,782,000 | 39,000 | 500,014 | 877,000 | 385,000 | 68,000 | -459,000 | -1,958,676 | |
| Dividends Paid | ||||||||||||||
| Retained Profit | -2,619,000 | -1,102,000 | -1,662,000 | -1,624,000 | -2,150,000 | -1,782,000 | 39,000 | 500,014 | 877,000 | 385,000 | 68,000 | -459,000 | -1,958,676 | |
| Employee Costs | 17,061,000 | 9,479,000 | 8,148,000 | 5,189,000 | 2,533,000 | 2,395,000 | 2,390,000 | 2,378,000 | 1,783,554 | |||||
| Number Of Employees | 397 | 365 | 334 | 184 | 181 | 153 | 235 | 175 | 159 | 160 | 145 | 87 | ||
| EBITDA* | -1,675,000 | -532,000 | -1,301,000 | -1,395,000 | -1,964,000 | -1,743,000 | 102,000 | 540,409 | 901,000 | 399,000 | 6,647,000 | 255,000 | -804,502 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 6,165,000 | 6,497,000 | 6,577,000 | 1,256,000 | 1,142,000 | 633,000 | 367,000 | 242,104 | 157,000 | 71,000 | 28,000 | 15,275,000 | 15,589,199 | 15,842,373 |
| Intangible Assets | ||||||||||||||
| Investments & Other | ||||||||||||||
| Debtors (Due After 1 year) | ||||||||||||||
| Total Fixed Assets | 6,165,000 | 6,497,000 | 6,577,000 | 1,256,000 | 1,142,000 | 633,000 | 367,000 | 242,104 | 157,000 | 71,000 | 28,000 | 15,275,000 | 15,589,199 | 15,842,373 |
| Stock & work in progress | 24,000 | 24,000 | 13,000 | 10,000 | 9,000 | 8,000 | ||||||||
| Trade Debtors | 32,000 | 66,000 | 908,000 | 579,000 | 383,000 | 2,003,000 | 363,000 | 444,317 | 672,000 | 564,000 | 348,000 | 110,000 | 125,221 | 53,798 |
| Group Debtors | 1,662,000 | 452,532 | 80,000 | 71,000 | 52,000 | 13,707 | ||||||||
| Misc Debtors | 417,000 | 270,000 | 283,000 | 223,000 | 117,000 | 107,000 | 148,000 | 465,398 | 456,000 | 409,000 | 477,000 | 53,000 | 45,369 | |
| Cash | 4,000 | 217,000 | 565,000 | 71,000 | 299,000 | 1,099,000 | 201,000 | 203,636 | 105,000 | 148,000 | 115,000 | 887 | 107,490 | |
| misc current assets | ||||||||||||||
| total current assets | 477,000 | 577,000 | 1,769,000 | 883,000 | 808,000 | 3,217,000 | 2,374,000 | 1,565,883 | 1,313,000 | 1,192,000 | 992,000 | 163,000 | 185,184 | 161,288 |
| total assets | 6,642,000 | 7,074,000 | 8,346,000 | 2,139,000 | 1,950,000 | 3,850,000 | 2,741,000 | 1,807,987 | 1,470,000 | 1,263,000 | 1,020,000 | 15,438,000 | 15,774,383 | 16,003,661 |
| Bank overdraft | 27,000 | 257,000 | 201,365 | |||||||||||
| Bank loan | 9,693,000 | 141,802 | ||||||||||||
| Trade Creditors | 138,000 | 174,000 | 159,000 | 345,000 | 361,018 | 160,000 | 106,000 | 152,000 | 104,000 | 221,044 | 9,061,580 | |||
| Group/Directors Accounts | 16,586,000 | 15,081,000 | 15,214,000 | 7,163,000 | 5,349,000 | 4,982,000 | 1,810,000 | 406,000 | 109,478 | |||||
| other short term finances | ||||||||||||||
| hp & lease commitments | 14,000 | 3,723 | ||||||||||||
| other current liabilities | 941,000 | 324,000 | 377,000 | 421,000 | 326,000 | 518,000 | 613,000 | 1,513,130 | 1,877,000 | 2,601,000 | 2,697,000 | 690,000 | 200,271 | |
| total current liabilities | 17,554,000 | 15,405,000 | 15,591,000 | 7,722,000 | 5,849,000 | 5,659,000 | 2,768,000 | 1,874,148 | 2,037,000 | 2,707,000 | 2,849,000 | 11,164,000 | 877,683 | 9,061,580 |
| loans | 10,149,272 | |||||||||||||
| hp & lease commitments | 14,023 | |||||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | 250,000 | |||||||||||||
| provisions | 54,000 | 16,000 | 60,000 | |||||||||||
| total long term liabilities | 54,000 | 16,000 | 60,000 | 10,163,295 | 250,000 | |||||||||
| total liabilities | 17,608,000 | 15,421,000 | 15,591,000 | 7,722,000 | 5,909,000 | 5,659,000 | 2,768,000 | 1,874,148 | 2,037,000 | 2,707,000 | 2,849,000 | 11,164,000 | 11,040,978 | 9,311,580 |
| net assets | -10,966,000 | -8,347,000 | -7,245,000 | -5,583,000 | -3,959,000 | -1,809,000 | -27,000 | -66,161 | -567,000 | -1,444,000 | -1,829,000 | 4,274,000 | 4,733,405 | 6,692,081 |
| total shareholders funds | -10,966,000 | -8,347,000 | -7,245,000 | -5,583,000 | -3,959,000 | -1,809,000 | -27,000 | -66,161 | -567,000 | -1,444,000 | -1,829,000 | 4,274,000 | 4,733,405 | 6,692,081 |
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -2,581,000 | -1,066,000 | -1,651,000 | -1,610,000 | -2,142,000 | -1,834,000 | 39,000 | 500,014 | 878,000 | 386,000 | 357,000 | -114,000 | -1,193,420 | |
| Depreciation | 906,000 | 534,000 | 350,000 | 215,000 | 178,000 | 91,000 | 63,000 | 40,395 | 23,000 | 13,000 | 6,290,000 | 369,000 | 388,918 | 45,813 |
| Amortisation | ||||||||||||||
| Tax | -38,000 | -36,000 | -11,000 | -14,000 | -8,000 | 53,000 | ||||||||
| Stock | 24,000 | 11,000 | 3,000 | 1,000 | 1,000 | 8,000 | ||||||||
| Debtors | 449,000 | -855,000 | 389,000 | 302,000 | -1,610,000 | -63,000 | 810,753 | 154,247 | 164,000 | 167,000 | 714,000 | -21,297 | 130,499 | 53,798 |
| Creditors | -138,000 | -36,000 | 15,000 | -186,000 | -16,018 | 201,018 | 54,000 | -46,000 | 48,000 | -117,044 | -8,840,536 | 9,061,580 | ||
| Accruals and Deferred Income | 941,000 | -53,000 | -44,000 | 95,000 | -192,000 | -95,000 | -900,130 | -363,870 | -724,000 | -96,000 | 2,007,000 | 489,729 | 200,271 | |
| Deferred Taxes & Provisions | 54,000 | 16,000 | -60,000 | 60,000 | ||||||||||
| Cash flow from operations | -1,191,000 | 239,000 | -1,886,000 | -1,713,000 | -480,000 | -1,916,000 | -1,624,901 | 223,310 | 67,000 | 90,000 | 7,988,000 | 648,982 | -9,575,266 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | ||||||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | -9,693,000 | 9,551,198 | 141,802 | |||||||||||
| Group/Directors Accounts | 16,586,000 | -133,000 | 8,051,000 | 1,814,000 | 367,000 | 3,172,000 | 1,810,000 | -406,000 | 296,522 | 109,478 | ||||
| Other Short Term Loans | ||||||||||||||
| Long term loans | -10,149,272 | 10,149,272 | ||||||||||||
| Hire Purchase and Lease Commitments | -14,000 | -3,746 | 17,746 | |||||||||||
| other long term liabilities | -250,000 | 250,000 | ||||||||||||
| share issue | ||||||||||||||
| interest | -1,000 | -1,000 | -1,000 | -289,000 | -345,000 | -765,256 | ||||||||
| cash flow from financing | 8,239,000 | -133,000 | 8,051,000 | 1,814,000 | 367,000 | 3,171,000 | 1,810,161 | 825 | -1,000 | -1,000 | -16,573,000 | -650,703 | 9,403,042 | |
| cash and cash equivalents | ||||||||||||||
| cash | 4,000 | -348,000 | 494,000 | -228,000 | -800,000 | 898,000 | -2,636 | 98,636 | -43,000 | 33,000 | 115,000 | -887 | -106,603 | 107,490 |
| overdraft | 27,000 | -257,000 | 55,635 | 201,365 | ||||||||||
| change in cash | -23,000 | -348,000 | 494,000 | -228,000 | -800,000 | 898,000 | -2,636 | 98,636 | -43,000 | 33,000 | 372,000 | -56,522 | -307,968 | 107,490 |
elysium neurological services (badby) limited Credit Report and Business Information
Elysium Neurological Services (badby) Limited Competitor Analysis
Perform a competitor analysis for elysium neurological services (badby) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in WD6 area or any other competitors across 12 key performance metrics.
elysium neurological services (badby) limited Ownership
ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED group structure
Elysium Neurological Services (Badby) Limited has no subsidiary companies.
Ultimate parent company
P HEALTH SARL
#0102578
2 parents
ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED
05558328
elysium neurological services (badby) limited directors
Elysium Neurological Services (Badby) Limited currently has 4 directors. The longest serving directors include Dr Quazi Haque (Apr 2017) and Mrs Kathryn Murphy (Sep 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Quazi Haque | 56 years | Apr 2017 | - | Director | |
| Mrs Kathryn Murphy | United Kingdom | 62 years | Sep 2020 | - | Director |
| Mr Colin McCready | United Kingdom | 49 years | Jul 2023 | - | Director |
| Miss Sheetal Shah | United Kingdom | 46 years | Oct 2024 | - | Director |
P&L
June 2023turnover
27.2m
0%
operating profit
-2.6m
0%
gross margin
14.6%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
-11m
0%
total assets
6.6m
0%
cash
4k
0%
net assets
Total assets minus all liabilities
elysium neurological services (badby) limited company details
company number
05558328
Type
Private limited with Share Capital
industry
86102 - Medical nursing home activities
incorporation date
September 2005
age
20
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
June 2023
previous names
badby park limited (May 2017)
accountant
-
auditor
-
address
2 imperial place, maxwell road, borehamwood, hertfordshire, WD6 1JN
Bank
-
Legal Advisor
-
elysium neurological services (badby) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 11 charges/mortgages relating to elysium neurological services (badby) limited. Currently there are 0 open charges and 11 have been satisfied in the past.
elysium neurological services (badby) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED. This can take several minutes, an email will notify you when this has completed.
elysium neurological services (badby) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
